WuXi AppTec has filed for a pre­lim­i­nary in­junc­tion to sus­pend its place on the Pen­ta­gon’s list of com­pa­nies with al­leged ties to the Chi­nese mil­i­tary.

The...

Mer­ck has axed a Phase 2 tri­al test­ing an ex­per­i­men­tal Alzheimer’s med­i­cine, End­points News has learned.

The com­pa­ny ter­mi­nat­eda mid-stage test of the oral...

An FDA warn­ing let­ter sent late last month to Gen­zyme's Ire­land-based man­u­fac­tur­ing site, now owned by Sanofi, rais­es sig­nif­i­cant qual­i­ty- and da­ta-re­lat­ed is­sues.

On da­ta...

The FDA gave the go-ahead to Or­ca Bio’s T cell ther­a­py that would re­duce trans­plant-re­lat­ed com­pli­ca­tions for blood can­cer pa­tients.

The ther­a­py will be brand­ed...

Bridge­Bio Phar­ma has re­loaded with about $1 bil­lion in a pre­ferred eq­ui­ty deal to bol­ster its re­serves ahead of three po­ten­tial drug launch­es over the...

Ipsen is on an M&A roll.

The French drug­mak­er an­nounced its sec­ond deal of the week, say­ing it would buyMemo Ther­a­peu­tics and its drug...